Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Onconetix (ONCO) Return on Sales (2023 - 2025)

Onconetix (ONCO) has disclosed Return on Sales for 2 consecutive years, with 118.99% as the latest value for Q4 2024.

  • On a quarterly basis, Return on Sales fell 23593.0% to 118.99% in Q4 2024 year-over-year; TTM through Dec 2024 was 0.19%, a 6335.0% decrease, with the full-year FY2024 number at 0.34%, up 63412.0% from a year prior.
  • Return on Sales was 118.99% for Q4 2024 at Onconetix, down from 9.41% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 116.94% in Q4 2023 to a low of 1762.63% in Q1 2023.